A detailed history of Clari Vest Asset Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 68,696 shares of HALO stock, worth $3.14 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
68,696
Previous 68,696 -0.0%
Holding current value
$3.14 Million
Previous $3.6 Million 9.29%
% of portfolio
0.39%
Previous 0.38%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$37.81 - $52.4 $5,406 - $7,493
143 Added 0.21%
68,696 $3.6 Million
Q1 2024

May 06, 2024

SELL
$33.68 - $41.95 $9,767 - $12,165
-290 Reduced 0.42%
68,553 $2.79 Million
Q4 2023

Feb 13, 2024

BUY
$33.32 - $42.1 $1.68 Million - $2.13 Million
50,562 Added 276.58%
68,843 $2.54 Million
Q2 2023

Aug 14, 2023

SELL
$30.28 - $38.74 $40,151 - $51,369
-1,326 Reduced 6.76%
18,281 $659,000
Q1 2023

May 08, 2023

SELL
$32.86 - $55.7 $91,679 - $155,403
-2,790 Reduced 12.46%
19,607 $749,000
Q4 2022

Feb 14, 2023

SELL
$40.06 - $59.44 $1,442 - $2,139
-36 Reduced 0.16%
22,397 $1.27 Million
Q3 2022

Nov 10, 2022

BUY
$38.53 - $51.78 $94,051 - $126,394
2,441 Added 12.21%
22,433 $888,000
Q1 2022

May 04, 2022

SELL
$31.97 - $41.06 $575 - $739
-18 Reduced 0.09%
19,992 $798,000
Q4 2021

Feb 14, 2022

SELL
$31.82 - $40.75 $39,329 - $50,367
-1,236 Reduced 5.82%
20,010 $805,000
Q3 2021

Nov 08, 2021

SELL
$38.47 - $46.42 $30,699 - $37,043
-798 Reduced 3.62%
21,246 $865,000
Q2 2021

Aug 09, 2021

SELL
$38.84 - $51.31 $3.92 Million - $5.18 Million
-100,960 Reduced 82.08%
22,044 $1 Million
Q1 2021

May 13, 2021

SELL
$39.51 - $51.45 $118,530 - $154,350
-3,000 Reduced 2.38%
123,004 $5.13 Million
Q4 2020

Feb 09, 2021

SELL
$25.81 - $43.62 $1.35 Million - $2.29 Million
-52,486 Reduced 29.41%
126,004 $5.38 Million
Q3 2020

Nov 09, 2020

SELL
$25.74 - $29.63 $152,612 - $175,676
-5,929 Reduced 3.21%
178,490 $4.69 Million
Q2 2020

Aug 12, 2020

BUY
$16.25 - $26.81 $76,960 - $126,972
4,736 Added 2.64%
184,419 $4.95 Million
Q1 2020

May 04, 2020

BUY
$13.9 - $21.83 $69,069 - $108,473
4,969 Added 2.84%
179,683 $3.23 Million
Q4 2019

Feb 12, 2020

BUY
$14.93 - $19.53 $1.55 Million - $2.03 Million
103,716 Added 146.08%
174,714 $3.1 Million
Q3 2019

Nov 12, 2019

SELL
$15.2 - $17.69 $15,200 - $17,690
-1,000 Reduced 1.39%
70,998 $1.1 Million
Q2 2019

Aug 16, 2019

SELL
$14.75 - $17.26 $8,850 - $10,356
-600 Reduced 0.83%
71,998 $1.24 Million
Q1 2019

May 13, 2019

SELL
$13.94 - $17.58 $74,760 - $94,281
-5,363 Reduced 6.88%
72,598 $1.17 Million
Q4 2018

Feb 05, 2019

BUY
$13.33 - $18.66 $401,512 - $562,057
30,121 Added 62.96%
77,961 $1.14 Million
Q3 2018

Nov 07, 2018

SELL
$16.68 - $18.41 $22,234 - $24,540
-1,333 Reduced 2.71%
47,840 $869,000
Q2 2018

Aug 10, 2018

SELL
$16.87 - $20.3 $25,524 - $30,713
-1,513 Reduced 2.99%
49,173 $831,000
Q1 2018

May 08, 2018

BUY
$17.06 - $21.2 $8,530 - $10,600
500 Added 1.0%
50,686 $993,000
Q4 2017

Feb 13, 2018

BUY
$16.75 - $20.8 $840,615 - $1.04 Million
50,186
50,186 $1.02 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.37B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.